Ornithine decarboxylase (ODC) is the most notable example of a protein degraded by the 26 S proteasome without ubiquitination. Instead, ODC is targeted to degradation by direct binding to a polyamine-induced protein termed antizyme (Az). Antizyme inhibitor (AzI) is an ODC-related protein that does not retain enzymatic activity yet binds Az with higher affinity than ODC. We show here that like ODC, AzI is also a short-lived protein that undergoes proteasomal degradation. However, in contrast to ODC degradation, the degradation of AzI is ubiquitin-dependent and does not require interaction with Az. Moreover, Az binding actually stabilizes AzI by inhibiting its ubiquitination. Substituting the C terminus of AzI with that of ODC, which together with Az constitutes the complete degradation signal of ODC, does not subvert AzI degradation from the ubiquitin-dependent mode to the Az-dependent mode, suggesting dominance of the ubiquitination signal. Our results suggest opposing roles of Az in regulating the degradation of AzI and ODC.
The polyamines spermine, spermidine, and their precursor putrescine are natural organic cations that play a crucial role in regulating fundamental cellular processes such as proliferation, differentiation, transformation, and apoptosis (1) (2) (3) (4) (5) (6) (7) (8) . The range of cellular polyamines is limited at the lower level by their essentiality for cellular proliferation and other fundamental cellular processes and at the higher limit by their cytotoxicity. Therefore, it is not surprising that cellular polyamines are highly regulated by multiple pathways such as biosynthesis, catabolism, uptake, and excretion. ODC 1 is a key enzyme in the polyamine biosynthesis pathway, and its degradation constitutes an important regulatory mechanism that controls cellular polyamines. ODC is actually one of the most rapidly degraded proteins in eukaryotic cells, and its degradation is unique in being manifested without ubiquitination (9, 10) . Instead, interaction with Az, a polyamine-induced protein (11, 12) , is required to target ODC for degradation by the 26 S proteasome (13) . Interaction of Az with ODC subunits has two outcomes: 1) ODC is inactivated due to trapping of transient ODC monomers by Az to form enzymatically inactive heterodimers (14) and 2) the Az/ODC heterodimers are presented to the proteasome, and ODC is degraded (13) (14) (15) (16) . Az was also demonstrated to regulate the process of polyamine transport across the plasma membrane via a yet unresolved mechanism (17, 18) . Az is rapidly degraded by the proteasome (19) ; however, its degradation does not occur while presenting ODC to the proteasome (19) . Furthermore, Az degradation requires the presence of an active ubiquitin system in the cells (19) . The ability of Az to regulate cellular polyamines by regulating both polyamine synthesis and uptake, together with the ability of polyamines to regulate its synthesis, suggest that Az synthesis functions as the cellular polyamine sensing mechanism and that Az is a central regulator of cellular polyamine metabolism.
Mammalian cells contain yet another protein termed antizyme inhibitor (AzI), which may be of great relevance to the regulation of cellular polyamines. AzI displays extensive homology to ODC but lacks decarboxylating activity (20) . AzI binds Az with higher affinity than ODC binds to Az; thus, it may save ODC from Az-mediated proteasomal degradation (20, 21) . AzI is induced in cells and tissues following growth stimulation (21) (22) (23) , and is elevated in gastric tumors (24) . The potential ability to regulate Az suggests that AzI may play an important role in regulating cellular polyamine levels and cell growth.
In the current study, we have studied the degradation of AzI. We show that AzI is degraded rapidly by the proteasome. In contrast to ODC degradation, which is greatly stimulated by Az, AzI degradation is inhibited by interaction with Az. Genetic and biochemical analysis reveal that AzI is degraded via the ubiquitin system and that interaction with Az interferes with its ubiquitination.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture-The cell lines used were: 293 human embryo kidney (293 HEK), NIH3T3 mouse fibroblasts, and A31N-ts20, a BALB/c mouse cell line that harbors a temperature-sensitive E1 ubiquitin-activating enzyme, and its parental cell line A31N (25) . Cells were grown in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 mg/ml streptomycin and cultured at 37°C in a humidified incubator with 5.6% CO 2 . A31N and A31N-ts20 were cultured at 32°C and transferred to 39°C to inactivate the E1 ubiquitin-activating enzyme in A31N-ts20 cells (25) .
Plasmids-DNA encoding AzI, Az (a clone that does not require frameshifting for expression), ODC, and HA-tagged ubiquitin were PCR-amplified using specific primers to which XhoI sites (5Ј primer) and NotI sites (3Ј primer) were appended. The PCR product was digested with XhoI and NotI and ligated into the bicistronic vector pE-FIRES (26) .
Mutagenesis-Mutations were introduced using the overlap extension method (27, 28) .
Transfections-Transient transfections of 293 HEK cells were carried out by the calcium phosphate method. Stable transfections of NIH3T3 cells and transient transfections of A31N and A31N-ts20 were carried out with jetPEI, a cationic polymer transfection reagent (Poly Transfection) according to the manufacturer's protocol. Stably transfected cells were selected for growth in the presence of puromycin (Sigma).
Immunoblot Analysis-Cell extracts were prepared by lysing phosphate-buffered saline-washed cells in radioimmune precipitation lysis buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 8, 1 mM dithiothreitol, and 1 g/ml each of leupeptin, aprotinin, and pepstatin (Sigma mixture)). The insoluble pellet was discarded, and protein concentration was determined using Bradford reagent (Bio-Rad). Equal amounts of protein were mixed with Laemmli sample buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, and 0.125 M Tris-HCl, pH 6.8), heated at 95°C for 5 min, and fractionated by electrophoresis in a 12.5% polyacrylamide-SDS gel. The resolved proteins were electroblotted to cellulose nitrate 0.45-m membranes (Schleicher & Schuell). The resulting blots were incubated with the indicated antibodies followed by horseradish peroxidase-conjugated anti-IgG antibodies. Signals were developed using Super Signal (Pierce) at 25°C for 5 min, and the membranes were exposed to x-ray film (Fuji) and developed. The antibodies used were: mouse monoclonal anti-ODC (Sigma), rabbit polyclonal anti-Az (14) , and rabbit polyclonal anti-AzI prepared in the present study using bacterially expressed AzI.
In Vitro Protein Degradation Assay-In vitro translated [ 35 S]methionine-labeled proteins were incubated in a reticulocyte lysate-based degradation mixture (40 mM Tris-HCl, pH 7.5, 5 mM MgCl 2 , 2 mM dithiothreitol, 0.5 mM ATP, 10 mM phosphocreatine (Sigma), 1.6 mg/ml creatine phosphokinase (Roche Applied Science), 200 g/ml ubiquitin (Sigma) and 6 l of reticulocyte lysate) at 37°C for the indicated times. At the end of the incubation, samples were mixed with Laemmli sample buffer, heated at 95°C for 5 min, and fractionated by electrophoresis in a 12.5% polyacrylamide-SDS gel, and the labeled protein was detected using the Fuji Bas2000 phosphorimaging device or by autoradiography.
In vitro Ub Conjugation Assay-A basic conjugation reaction is composed of 40 mM Tris-HCl, pH 7.6, 5 mM MgCl 2 , 2 mM dithiothreitol, 0.1 mM MG132, 5 mM ATP␥S, 0.5 l of Ub-aldehyde, 8 l of reticulocyte lysate (Promega biotech), and 35 [S]methionine-labeled assayed protein. The conjugation assay was performed for 60 min at 37°C (when AzI was tested) or 30°C (when p53 was tested). When the ATP requirement for conjugation was tested, 10 mM 2-deoxyglucose and 150 units of hexokinase were added prior to the addition of the labeled protein, MG132, ATP␥S, and Ub-aldehyde, and the mixture was incubated for 5 min at 37°C to deplete ATP.
In Vivo Ub Conjugation Assay-Twenty hours after co-transfection with the constructs encoding the tested protein and HA-Ub, the cells were treated for 4 h with MG132 (100 M) and harvested, and cellular extracts were prepared in radioimmune precipitation lysis buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 8, 1 mM dithiothreitol, and 1 g/ml each of leupeptin, aprotinin, pepstatin (Sigma mixture)). Aliquots containing equal amounts of proteins were immunoprecipitated with anti-ODC, anti-AzI (prepared in our laboratory), and anti-p53 (kindly provided by M. Oren) antibodies. The immunoprecipitated material was resolved by electrophoresis in an SDS-polyacrylamide gel, transferred to nitrocellulose, and probed with anti-HA antibodies (Sigma) 35 [S]ODC was incubated in a reticulocyte lysate-based degradation mix either alone or together with Az or Az ϩ AzI. Following 2 h of incubation, samples were fractionated by electrophoresis in an SDS-polyacrylamide gel, and the radioactive bands were visualized using a Fuji Bas2500 phosphorimaging device. It should be noted that AzI migrates at the same position as the lower ODC band, and therefore, the presence of AzI is reflected by the increased intensity of the lower band. The part of the gel containing Az is not shown. C, cycloheximide (CHX, 20 g/ml) was added to the medium of AzI or ODC overproducing NIH3T3 cells either alone or together with the proteasome inhibitor MG132. Cellular extracts were prepared at time 0 and after 30 and 60 min. Aliquots containing equal amounts of proteins were fractionated by electrophoresis in an SDS-polyacrylamide gel, blotted to nitrocellulose, and probed with anti-AzI or anti-ODC antibodies. (20, 21) (Fig. 1A) . AzI has a higher affinity to Az, and therefore, it can rescue ODC from Az-stimulated degradation (20, 21) (Fig. 1B) . The potential ability of AzI to function as a regulator of ODC stability and polyamine uptake prompted us to investigate whether AzI is a short-lived protein. For this purpose, we have generated NIH3T3 cell lines expressing AzI or ODC (see "Experimental Procedures"). Cellular extracts were prepared at various times following the addition of cycloheximide to the growth medium, and the levels of AzI and ODC were determined by Western blot analysis. As shown in Fig. 1C , AzI has a very short half-life and is degraded even more rapidly than ODC. Since AzI degradation was completely prevented by MG132 (Fig. 1C) , we concluded that AzI is degraded by the proteasome.
RESULTS

AzI Is Rapidly Degraded by the
AzI Degradation Does Not Require Interaction with Az nor Its C Terminus-Two segments of ODC are required for its Az-dependent degradation. The first, encompassing amino acids 117-140 of the mouse enzyme, constitutes the Az binding site (15) (Figs. 1A and 2) . The second, which contains the 37 most C-terminal amino acids of ODC, is for recognition of ODC by the 26 S proteasome (29 -31) (Figs. 1A and 2 ). Although the Az binding site of AzI is similar to that of ODC, the C terminus of AzI shares only minimal homology to that of ODC (Fig. 2 , A and C, respectively). Changing the sequence of the Az binding segment of mouse ODC to the sequence of the corresponding segment of trypanosome ODC that does not bind to Az (see Fig.  2A for the list of altered amino acids) resulted in significant stabilization of the mutant denoted ODC-MTM (14) . To test whether Az binding is required for the degradation of AzI, nine mutations were introduced into the Az binding segment of AzI, yielding the AzI-MTM mutant (see Fig. 2A for the list of altered amino acids) that does not bind Az. The ODC-MTM and AzI-MTM mutants were transiently expressed in 293 cells, and their stability was determined. Although as reported previously, the ODC-MTM mutant was stable, AzI-MTM was rapidly degraded (Fig. 2B) , demonstrating that interaction with Az is not required for AzI degradation. This result agrees with the previous demonstration that AzI degradation in rat hepatoma cells extract was not stimulated by Az (20) .
As stated above, alignment of the sequences of AzI and ODC reveals extensive differences in their c-terminal segments (Fig.  2C) . Since minor changes within the C-terminal segment of ODC inhibited degradation, these differences by themselves suggest that the C-terminal segment of AzI is not required for its degradation. To test this directly, the C-terminal segment of AzI was deleted, and the stability of the resulting mutant was determined in transfected 293 cells. As shown in Fig. 2D , the AzI mutant lacking the C-terminal segment (amino acids 418 -448) was rapidly degraded, whereas the parallel ODC mutant (lacking amino acids 423-461) was significantly stabilized. We therefore conclude that Az binding and the C-terminal segment are not required for AzI degradation.
AzI Degradation Requires Ubiquitination-Since we demonstrate here that AzI degradation does not require interaction with Az and that its C-terminal segment does not serve as a degradation signal, we set out to investigate the possibility that AzI is degraded via the ubiquitin system, as is the degradation of the majority of cellular proteins. The following four experimental systems were used to determine whether AzI degradation requires ubiquitination. 1) AzI was transiently transfected into A31N-ts20 cells (25) that contain a thermosensitive ubiquitin-activating enzyme, E1, and into their parental A31N cells, and the transfected cells were maintained at the permissive temperature (32°C). Twentyfour hours after transfection, half of the cells were transferred to the restrictive temperature (39°C) for 24 h. Cellular extracts were then prepared, and the level of AzI was determined by Western blot analysis. AzI accumulated only in A31N-ts20 cells, upon their transfer to the non-permissive temperature (39°C) (Fig. 3A) . 2) AzI was translated in vitro in reticulocyte lysate in the presence of 35 [S]methionine and subjected to degradation in a reticulocyte lysate-based degradation mix or in fraction II of reticulocyte lysate (F-II) that is depleted of ubiquitin. AzI was degraded in reticulocyte lysate-based degradation mix (Fig. 3B) but remained stable when incubated in fraction II (Fig. 3B) . As reported before (9), ODC was efficiently degraded degraded in fraction II of reticulocyte lysate (Fig. 3B, F-II) . 3) FLAG-tagged AzI or GFP was transfected into 293 cells together with HA-tagged ubiquitin. Cellular extracts were prepared and subjected to immunoprecipitation with anti-FLAG antibodies, and the precipitated material was subjected to Western blot analysis using anti-HA antibodies. High molecular weight Ub conjugates were clearly observed in AzI-transfected cells but not in the GFP-transfected cells (Fig. 3C) . 4) AzI, ODC, and p53 were synthesized in vitro in reticulocyte lysate in the presence of 35 [S]methionine. Conjugation to ubiquitin was performed in rabbit reticulocyte lysate in the presence of MG132, ␥-S-ATP, and Ub-aldehyde (see "Experimental Procedures" for details). Ubiquitinated AzI was clearly observed (Fig. 3D) . As expected, ODC remained unubiquitinated, whereas p53 was efficiently conjugated to Ub (Fig. 3D) . The formation of both p53 and AzI conjugates required metabolic energy in the form of ATP (Fig. 3D) . Based on these four independent criteria, we concluded that in contrast to ODC that is degraded by the proteasome without ubiquitination, AzI is degraded in a Ub-dependent manner.
Interaction with Az Stabilizes AzI-Although the above experiments suggested that interaction with Az is not required
FIG. 2. AzI degradation does not require Az binding nor the C terminus.
A, the sequence of the Az binding site of mouse ODC (mODC) and the parallel sequence of AzI and of trypanosome ODC (a form of ODC that does not bind Az) are presented. The mutations introduced into mouse ODC to generate the ODC-MTM mutant and into AzI to generate the AzI-MTM mutant are indicated by arrowheads. B, AzI-MTM and ODC-MTM were transiently expressed in 293 cells, and the degradation rate of the expressed proteins was determined as described in the legend for Fig. 1C . CHX, cycloheximide. C, the sequence of the C-terminal degradation signal of mouse ODC and the parallel region of AzI are presented. Deletion mutants lacking these segments were prepared as described under "Experimental Procedures." D, the resulting AzI⌬C-ter and ODC⌬C-ter mutants were transiently expressed in 293 cells. The degradation rate of the expressed proteins were determined as described in the legend for Fig. 1C. for AzI degradation, Az is present in cells and binds AzI with high affinity (20) . Therefore, we next set out to determine whether there will be any effect resulting from the interaction of AzI with Az. For this purpose, AzI and ODC were each expressed together with Az in 293 cells, and their level was determined. As expected, Az destabilized ODC so efficiently that ODC was practically undetectable in the transfected cells (Fig. 4A) . In sharp contrast, AzI was dramatically stabilized when co-expressed with Az (Fig. 4A) . No inhibition was observed when the AzI-MTM mutant was co-expressed with Az (Fig. 4A) . Our results therefore demonstrate that Az stabilizes AzI and that binding to AzI is required for this stabilization. Interestingly, Az is also stabilized due to its interaction with AzI as demonstrated by its increased accumulation when it is co-transfected with increasing amounts of AzI (Fig. 4B) .
Az Inhibits AzI Ubiquitination-Having demonstrated that Az inhibits AzI degradation and that AzI degradation is Ubdependent, we next set out to determine how Az interferes with this Ub-dependent degradation. We first tested whether Az interferes with the conjugation of Ub to AzI. For this purpose, FLAGAzI and HA-Ub were co-expressed in 293 cells with or without Az. Cellular extracts were immunoprecipitated with anti-FLAG antibodies, and the precipitated material was resolved by electrophoresis and probed with anti-HA antibody. As shown in Fig. 5A , Az inhibited the conjugation of Ub to AzI. This effect of Az is specific, as co-expressed Az did not affect the MDM2-mediated conjugation of Ub to p53 (Fig. 5B) . The ability of Az to inhibit conjugation of Ub to AzI requires binding of Az to AzI as determined by the inability of co-transfected Az to reduce conjugation of Ub to the AzI-MTM mutant (Fig. 5C) . The actual decrease in the amount of AzI-Ub conjugates is even greater than visualized in Fig. 5C as there is a great increase in Twenty-four hours after transfection, cycloheximide (CHX, 20 g/ml) was added, and cellular extracts were prepared at the indicated times. Equal portions of proteins were fractionated by electrophoresis in an SDS-polyacrylamide gel, blotted to nitrocellulose, and probed with antiAzI and anti-ODC antibodies. B, the Az-encoding construct was transfected into 293 cells either alone or together with increasing concentrations of the AzI-expressing construct. The total amount of transfected DNA was normalized with empty vector DNA. Cellular extracts were prepared 24 h after transfection, and equal portions of proteins were fractionated by electrophoresis in an SDS-polyacrylamide gel, blotted to nitrocellulose, and probed with anti-Az antibodies. NS, nonspecific.
FIG. 3. AzI is targeted for degradation by ubiquitination.
A, a construct encoding AzI was transiently transfected into A31A (WT) and A31N-ts20 (ts20) harboring a temperature-sensitive Ub-activating enzyme. Twenty-four hours after transfection, half of the cells were transferred from the permissive temperature (32°C) to the restrictive temperature (39°C) for 24 h. Cellular extracts were prepared, and equal portions of proteins were fractionated by electrophoresis in an SDS-polyacrylamide gel and blotted to nitrocellulose. The level of AzI was determined using anti-AzI antibodies. B, in vitro translated 35 S-labeled AzI and ODC were incubated either in a complete rabbit reticulocyte lysate-based degradation mix (RRL) or in fraction II of reticulocyte lysate (F-II) that lacks Ub. Aliquots were removed at the indicated times, fractionated by electrophoresis in an SDS-polyacrylamide gel, and the proteins were visualized by the Fuji Bas2500 phosphorimaging device. C, FLAGAzI or FLAGGFP were transiently expressed in 293 cells together with HA-Ub. Twenty-four hours after transfection, cellular extracts were prepared and subjected to immunoprecipitation (IP) with anti-FLAG antibodies. The precipitated material was fractionated by electrophoresis in an SDSpolyacrylamide gel, blotted to nitrocellulose, and probed with anti-HA antibodies. D, 35 S-labeled AzI, ODC, and p53 were synthesized in vitro by translation in reticulocyte lysate and incubated in a conjugation reaction as outlined under "Experimental Procedures." After 60 min of incubation, the material was fractionated by electrophoresis in an SDS-polyacrylamide gel, and radioactivity was visualized using the Fuji Bas2500 phosphorimaging device.
the amount of AzI in the presence of Az due to its stabilization (Fig. 5D) .
AzI⅐ODC Chimera That Contains the C-terminal Destabilizing Signal of ODC Is Degraded in a Ubiquitin-dependent Man
ner-We demonstrate here that AzI and ODC are two highly homologous related proteins that are recognized for proteasomal degradation by two different mechanisms. We therefore use these two related proteins to determine which mode of degradation, Ub-dependent or Az-dependent, will prevail. As demonstrated above, AzI possesses the segment required for Az binding but lacks a C-terminal degradation signal. We therefore decided to append the C-terminal destabilizing segment of ODC in place of the C-terminal segment of AzI and test whether this change will divert AzI degradation from the Ubdependent pathway to the Az-dependent pathway. To do so, an NcoI site was introduced into the C terminus of AzI in a position that parallels the NcoI site of ODC. Next, the Cterminal segment of AzI was replaced with that of ODC (Fig.  6A) . The resulting protein, denoted AzI⅐ODC, was expressed in 293 cells alone or together with Az. AzI⅐ODC behaved as AzI; namely, it was rapidly degraded, and this degradation was inhibited by co-expressed Az (Fig. 6B) . These results strongly suggest that the signal that directs AzI to Ub-dependent degradation dominates. DISCUSSION We show here that AzI, an ODC-related protein, is rapidly degraded in a Ub-dependent manner. Although Ub dependence is a standard feature in cellular protein degradation, Ub dependence in the case of AzI degradation is rather surprising since ODC is the most notable example of a short-lived cellular protein that undergoes Ub-independent degradation and since AzI shares significant homology with ODC. Although retaining strong binding affinity to Az, the C-terminal segment of AzI differs significantly from the sequence of the C-terminal degradation signal of ODC (Fig. 1A) . It was therefore remarkable to find out that AzI was degraded even more rapidly than ODC. Moreover, mutant AzI lacking the entire C-terminal segment was still rapidly degraded, suggesting that the mechanism of AzI degradation is different from that of ODC degradation. It is interesting to note in this respect that yeast and trypanosome ODC, which naturally lack the C-terminal degradation signal, are both stable when expressed in mammalian cells (32, 33) .
Az-mediated degradation is a unique process for the degradation of ODC, although it has recently been demonstrated that Az may also mediate the degradation of cyclin D1 (34) . The majority of cellular proteins need to be polyubiquitinated prior to their recognition and degradation by the 26 S proteasome. We show here that in contrast to ODC degradation, AzI degradation requires polyubiquitination. This conclusion is based on results we obtained using several parallel experimental approaches. AzI accumulates in cells harboring temperaturesensitive ubiquitin activating enzyme when these cells are incubated at the non-permissive temperature. AzI is stable in fraction II of reticulocyte lysate, which lacks Ub, whereas ODC is efficiently degraded in this fraction. AzI⅐Ub conjugates are readily observed after co-expression of AzI and HA-Ub in transfected cells or when AzI and Ub are co-incubated in vitro in reticulocyte lysate. Interestingly, AzI was degraded in a Ubdependent manner even when its C terminus was replaced by the C-terminal destabilizing signal of ODC, suggesting preferred recognition and channeling of AzI degradation to the Ub-dependent pathway.
Degradation of mammalian ODC is greatly stimulated by Az via a unique mechanism of targeting to the 26 S protea- Fig. 3C . IP, immunoprecipitation. B, p53, mdm2, and HA-Ub were co-transfected into 293 cells with or without Az. Cellular extracts were immunoprecipitated with anti-p53 antibody followed by Western blot analysis as described in the legend for Fig. 3C . C, wild-type AzI (AzI wt) and the AzI-MTM mutant were expressed in 293 cells with and without Az. The formation of AzI⅐Ub conjugates was determined as described in the legend for Fig. 3C . D, cellular extracts analyzed in C were directly fractionated by electrophoresis in SDS-polyacrylamide gel, blotted to nitrocellulose, and probed with anti-AzI antibodies. 418 -448) . B, the AzI⅐ODC chimera was expressed in 293 cells with or without Az, and its stability was determined as described in the legend for Fig. 1C . CHX, cycloheximide.
some (for a review, see Ref. 35) . We show here not only that AzI degradation does not require Az but also that Az binding actually stabilizes AzI. This negating effect of Az on ODC and AzI may represent an important aspect of the polyamine regulating circuit. Since AzI can sequester Az, it is possible that AzI provides fine-tuning in the ability of Az to stimulate ODC degradation and inhibit polyamine uptake. For instance, the observation that AzI is induced during growth stimulation similarly to ODC (21) suggests that AzI may buffer Az, which appears upon increase of the intracellular concentration of polyamines. Our results demonstrate that both AzI and Az are stabilized upon their interaction. Therefore, it will be of interest to determine whether their association/dissociation is a regulated process and whether this process is affected by the intracellular polyamines. The ability of AzI to sequester Az and neutralize its ability to stimulate ODC degradation and inhibit polyamine uptake suggests that it may act as a central regulator of cellular polyamine homeostasis. Indeed, our recent studies demonstrate growth advantage of AzI overexpressing cells.
We show that the inhibitory effect of Az on the degradation of AzI is exerted by inhibition of AzI ubiquitination. The ability of Az to prevent Ub-dependent degradation appears to be specific to AzI, as Az did not affect the ubiquitination of p53. It has been suggested that Az stimulates ODC degradation by imposing conformational changes that result in exposing its C-terminal degradation signal (36) . It is possible that similarly, Az inflicts conformational changes on AzI that hide its degradation signal. Alternatively, it is possible that Az competes with an E3 on binding to AzI. It will be of interest to identify the components of the Ub system, e.g. the E2 and E3 that mediate the ubiquitination of AzI as well as the signal that mediates the recognition of AzI by the Ub system.
